Premium
Carbon Nanomaterials Promote M1/M2 Macrophage Activation
Author(s) -
Kinaret Pia Anneli Sofia,
Scala Giovanni,
Federico Antonio,
Sund Jukka,
Greco Dario
Publication year - 2020
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201907609
Subject(s) - macrophage polarization , secretion , tumor necrosis factor alpha , macrophage , cytokine , cytotoxic t cell , in vivo , microbiology and biotechnology , tumor microenvironment , proinflammatory cytokine , biology , chemistry , cell , in vitro , immune system , immunology , inflammation , biochemistry , genetics
Toxic effects of certain carbon nanomaterials (CNM) have been observed in several exposure scenarios both in vivo and in vitro. However, most of the data currently available has been generated in a high‐dose/acute exposure setup, limiting the understanding of their immunomodulatory mechanisms. Here, macrophage‐like THP‐1 cells, exposed to ten different CNM for 48 h in low‐cytotoxic concentration of 10 µg mL −1 , are characterized by secretion of different cytokines and global transcriptional changes. Subsequently, the relationships between cytokine secretion and transcriptional patterns are modeled, highlighting specific pathways related to alternative macrophage activation. Finally, time‐ and dose‐dependent activation of transcription and secretion of M1 marker genes IL‐1β and tumor necrosis factor, and M2 marker genes IL‐10 and CSF1 is confirmed among the three most responsive CNM, with concentrations of 5, 10, and 20 µg mL −1 at 24, 48, and 72 h of exposure. These results underline CNM effects on the formation of cell microenvironment and gene expression leading to specific patterns of macrophage polarization. Taken together, these findings imply that, instead of a high and toxic CNM dose, a sub‐lethal dose in controlled exposure setup can be utilized to alter the cell microenvironment and program antigen presenting cells, with fascinating implications for novel therapeutic strategies.